Structures by: Thakur T. S.
Total: 83
Octa-bromo Perylenecarboxylicdianhydride
C24Br8O6,2(C4H8O)
Organic letters (2016) 18, 3 472-475
a=21.0972(18)Å b=15.0686(13)Å c=14.2085(12)Å
α=90° β=128.249(2)° γ=90°
4-Flurobenzoic acid
C7H5FO2
The journal of physical chemistry. A (2011) 115, 45 12852-12863
a=3.816(6)Å b=6.3759(11)Å c=26.571(4)Å
α=90° β=94.353(18)° γ=90°
4-Flurobenzoic acid
C7H5FO2
The journal of physical chemistry. A (2011) 115, 45 12852-12863
a=3.7812(8)Å b=6.3418(13)Å c=26.539(5)Å
α=90° β=94.11(3)° γ=90°
2-fluorobenzoic acid
C7H5FO2
The journal of physical chemistry. A (2011) 115, 45 12852-12863
a=6.5525(13)Å b=3.7524(8)Å c=25.021(5)Å
α=90° β=92.82(3)° γ=90°
2-fluorobenzoic acid:Isonicotinamide
C7H4FO2,C6H6N2O
The journal of physical chemistry. A (2011) 115, 45 12852-12863
a=7.0275(9)Å b=7.4474(9)Å c=12.6005(16)Å
α=74.371(5)° β=87.185(6)° γ=70.004(5)°
P-flurobenzoic acid
C7H5FO2
The journal of physical chemistry. A (2011) 115, 45 12852-12863
a=3.7041(2)Å b=6.2642(4)Å c=26.6604(17)Å
α=90° β=92.960(3)° γ=90°
4-fluorobenzoic acid
C7H5FO2
The journal of physical chemistry. A (2011) 115, 45 12852-12863
a=3.7411(7)Å b=6.3050(13)Å c=26.564(5)Å
α=90° β=93.54(3)° γ=90°
4-fluorobenzoic acid
C7H5FO2
The journal of physical chemistry. A (2011) 115, 45 12852-12863
a=3.7637(8)Å b=6.3314(13)Å c=26.607(5)Å
α=90° β=93.76(3)° γ=90°
3-fluorobenzoic acid
C7H5FO2
The journal of physical chemistry. A (2011) 115, 45 12852-12863
a=6.7465(13)Å b=3.7192(7)Å c=24.285(5)Å
α=90° β=92.91(3)° γ=90°
4-flurobenzoic acid:Isonicotinamide
C7H5FO2,C6H6N2O
The journal of physical chemistry. A (2011) 115, 45 12852-12863
a=22.046(3)Å b=5.2078(6)Å c=20.995(3)Å
α=90° β=95.888(8)° γ=90°
(+/-)-Synephrine Succinic Acid (1:0.5) Salt
C9H14NO2,0.5(C4H4O4)
Physical Chemistry Chemical Physics (2019)
a=5.8474(10)Å b=8.9093(15)Å c=11.586(2)Å
α=99.477(7)° β=93.462(7)° γ=107.504(8)°
(+/-)-Synephrine Fumaric Acid (1:0.5) Salt
C9H14NO2,0.5(C4H2O4)
Physical Chemistry Chemical Physics (2019)
a=13.045(2)Å b=5.6577(8)Å c=16.169(3)Å
α=90° β=107.412(17)° γ=90°
(+/-)-Synephrine Glutaric acid (1:0.5) Salt
2(C9H14NO2),C5H6O4
Physical Chemistry Chemical Physics (2019)
a=17.704(7)Å b=6.200(3)Å c=21.990(10)Å
α=90° β=98.751(11)° γ=90°
(+/-)-Synephrine adipic acid (1:0.5) Salt Monohydrate
C9H14NO2,0.5(C6H8O4),H2O
Physical Chemistry Chemical Physics (2019)
a=28.0334(19)Å b=5.4264(2)Å c=18.2828(10)Å
α=90° β=99.968(7)° γ=90°
(+/-)-Synephrine Oxalic Acid (1:0.5) Salt
C9H14NO2,0.5(C2O4)
Physical Chemistry Chemical Physics (2019)
a=12.997(7)Å b=7.236(4)Å c=12.376(6)Å
α=90° β=116.81(2)° γ=90°
(+/-)-Synephrine
C9H13NO2
Physical Chemistry Chemical Physics (2019)
a=8.869(5)Å b=12.103(6)Å c=9.009(4)Å
α=90° β=113.400(8)° γ=90°
Synephrine-DL-Malic acid 1:0.5 salt
2(C9H14NO2),C4H2O4,HO
Physical Chemistry Chemical Physics (2019)
a=5.7487(3)Å b=8.9795(5)Å c=11.6493(6)Å
α=100.209(5)° β=90.688(4)° γ=106.188(5)°
(+/-)-Synephrine adipic acid (1:0.5) Salt monolhydrate
C9H14NO2,0.5(C6H8O4),H2O
Physical Chemistry Chemical Physics (2019)
a=28.333(10)Å b=5.2410(15)Å c=18.325(6)Å
α=90° β=100.435(5)° γ=90°
Synephrine-DL-Tartaric acid 2:1 salt
2(C9H14NO2),C4H4O6
Physical Chemistry Chemical Physics (2019)
a=9.5357(3)Å b=11.1714(3)Å c=11.4964(3)Å
α=89.067(2)° β=70.401(3)° γ=79.552(2)°
(+/-) Synephrine L-tarataric acid salt (2:1)
2(C9H14NO2),C4H4O6
Physical Chemistry Chemical Physics (2019)
a=5.6127(4)Å b=9.3029(7)Å c=11.6456(6)Å
α=101.243(5)° β=91.903(5)° γ=105.888(6)°
(+/-)Synephrine Terephthalic acid (1:0.5) monohydrate
C9H14NO2,0.5(C8H4O4),H2O
Physical Chemistry Chemical Physics (2019)
a=15.4695(12)Å b=11.6758(5)Å c=15.9648(10)Å
α=90° β=112.858(8)° γ=90°
4-aminothiphenol
C6H7NS
Chemical Communications (2004) 22 2526-2527
a=7.2305(12)Å b=5.8513(10)Å c=7.7552(13)Å
α=90.00° β=107.364(3)° γ=90.00°
Formaldehyde
CH2O
Physical chemistry chemical physics : PCCP (2011) 13, 31 14076-14091
a=8.7411(10)Å b=8.7411(10)Å c=4.4740(9)Å
α=90.00° β=90.00° γ=90.00°
C3H4O
C3H4O
Physical chemistry chemical physics : PCCP (2011) 13, 31 14076-14091
a=7.134(8)Å b=9.694(11)Å c=9.930(10)Å
α=90.00° β=90.00° γ=90.00°
N-methylformamide
C2H5NO
Physical chemistry chemical physics : PCCP (2011) 13, 31 14076-14091
a=8.7855(6)Å b=8.5307(6)Å c=8.6148(7)Å
α=90.00° β=90.207(4)° γ=90.00°
Nigerloxin dioxane water solvate
C10H7NO5,0.5(C4H8O2),H2O
CrystEngComm (2016) 18, 10 1740
a=28.77(3)Å b=8.771(8)Å c=10.2110(10)Å
α=90° β=108.17(3)° γ=90°
Nigerloxin monohydrate
C10H7NO5,H2O
CrystEngComm (2016) 18, 10 1740
a=11.277(4)Å b=8.788(3)Å c=9.851(4)Å
α=90° β=96.003(7)° γ=90°
Levofloxacin hemihydrate
2(C18H20FN3O4),H2O
CrystEngComm (2014) 16, 20 4215
a=29.127(3)Å b=6.8850(2)Å c=18.8490(8)Å
α=90° β=114.089(6)° γ=90°
Levofloxacin Malonic Acid Hydrate
C18H21FN3O4,0.79(C3O4),0.21(C2O2),0.21(CO2),O
CrystEngComm (2014) 16, 20 4215
a=17.856(3)Å b=6.989(1)Å c=36.502(7)Å
α=90° β=99.282(6)° γ=90°
Levofloxacin Monohydrate
C18H20FN3O4,H2O
CrystEngComm (2014) 16, 20 4215
a=6.745(5)Å b=13.836(9)Å c=18.393(12)Å
α=90° β=95.380(11)° γ=90°
Levofloxacin Tetramethylene glutaric acid salt
C18H21FN3O4,C8.58H8O3.16,0.42(CO2)
CrystEngComm (2014) 16, 20 4215
a=18.1030(12)Å b=6.7410(4)Å c=23.9230(17)Å
α=90° β=93.800(7)° γ=90°
Levofloxacin Maleic acid salt
C18H20FN3O4,0.78(C4O4),0.22(C3O2),0.22(CO2)
CrystEngComm (2014) 16, 20 4215
a=6.830(4)Å b=34.84(2)Å c=9.908(6)Å
α=90° β=105.713(12)° γ=90°
Levofloxacin 3,5-dinitrobenzoate 1:2
C18H21FN3O4,C7H4N2O6,C7H3N2O6
CrystEngComm (2014) 16, 20 4215
a=9.135(2)Å b=12.008(3)Å c=16.533(5)Å
α=79.910(13)° β=78.135(14)° γ=73.833(13)°
6(C18H21FN3O4),3(C2O4),11(O)
6(C18H21FN3O4),3(C2O4),11(O)
CrystEngComm (2014) 16, 20 4215
a=9.984(2)Å b=17.199(3)Å c=19.058(4)Å
α=67.254(8)° β=86.503(12)° γ=77.145(11)°
C18H21FN3O4,0.5(C4O4),2(O)
C18H21FN3O4,0.5(C4O4),2(O)
CrystEngComm (2014) 16, 20 4215
a=17.06(2)Å b=6.916(7)Å c=19.12(2)Å
α=90° β=110.106(17)° γ=90°
1.2.3.5-Tetrafluorobenzene
C6H2F4
CrystEngComm (2010) 12, 7 2079
a=3.703(4)Å b=14.572(17)Å c=10.573(13)Å
α=90.00° β=96.340(19)° γ=90.00°
3-fluorobenzoic acid:Isonicotinamide
C7H5FO2,C6H6N2O
The journal of physical chemistry. A (2011) 115, 45 12852-12863
a=22.913(2)Å b=5.2046(5)Å c=20.0132(18)Å
α=90° β=100.212(7)° γ=90°
1-formyl-3-thiosemicarbazide
C2H5N3OS
Acta Crystallographica Section B (2006) 62, 1 118-127
a=7.2569(17)Å b=7.4263(18)Å c=9.593(2)Å
α=90° β=98.606(4)° γ=90°
1-formyl-3-thiosemicarbazide
C2H5N3OS
Acta Crystallographica Section B (2006) 62, 1 118-127
a=7.2339(5)Å b=7.3703(5)Å c=9.4771(7)Å
α=90.00° β=98.4260(10)° γ=90.00°
1-Formyl-3-thiosemicarbazide
C2H5N3OS
Acta Crystallographica Section B (2006) 62, 1 118-127
a=7.2359(3)Å b=7.3713(3)Å c=9.4768(4)Å
α=90° β=98.403(2)° γ=90°
2,6-dibromo-1-chloro-4-fluorobenzene
C6H2Br2ClF
Acta Crystallographica Section B Structural Science (2009) 65, 2 107-125
a=3.8943(5)Å b=13.5109(17)Å c=14.4296(17)Å
α=90.00° β=93.636(2)° γ=90.00°
2-amino-4-methylpyrimidine, 2-methylbenzoic acid
(C6H7N3),(C7H8O2)
Acta Crystallographica Section B Structural Science (2009) 65, 2 107-125
a=7.2795(10)Å b=13.6699(18)Å c=12.6695(16)Å
α=90.00° β=96.646(3)° γ=90.00°
C3H4O1
C3H4O1
Acta Crystallographica Section B Structural Science (2009) 65, 2 107-125
a=6.970(3)Å b=9.514(5)Å c=9.752(5)Å
α=90° β=90° γ=90°
Anisaldehyde
C8H8O2
Acta Crystallographica Section C (2011) 67, 10 o387-o390
a=4.970(4)Å b=9.034(9)Å c=15.544(14)Å
α=90.00° β=90.00° γ=90.00°
Salicylylaldehyde
C7H6O2
Acta Crystallographica Section C (2011) 67, 10 o387-o390
a=6.3945(3)Å b=13.8939(9)Å c=6.9172(4)Å
α=90.00° β=103.262(3)° γ=90.00°
Cinnamaldehyde
C9H8O
Acta Crystallographica Section C (2011) 67, 10 o387-o390
a=5.9626(2)Å b=12.9977(3)Å c=9.2522(2)Å
α=90.00° β=94.282(2)° γ=90.00°
Quinoxaline
C8H6N2
Acta Crystallographica Section E (2010) 66, 11 o2789
a=4.0212(13)Å b=7.187(2)Å c=23.095(7)Å
α=90° β=90° γ=90°
1,3-Difluorobenzene
C6H4F2
Acta Crystallographica Section E (2009) 65, 11 o2668-o2669
a=24.6618(13)Å b=12.2849(5)Å c=7.2336(4)Å
α=90.00° β=106.842(3)° γ=90.00°
1,2,3-Trifluorobenzene
C6H3F3
Acta Crystallographica Section E (2009) 65, 11 o2670
a=7.4238(19)Å b=11.590(3)Å c=7.0473(17)Å
α=90.00° β=112.783(4)° γ=90.00°
Orcinol:Urea
C7H8O2,2(CH4N2O)
Crystal Growth & Design (2011) 11, 6 2637
a=16.602(3)Å b=10.546(2)Å c=7.0700(14)Å
α=90° β=99.30(3)° γ=90°
Orcinol:N,NdimethylaminoPyridne
2(C7H10N2),2(C7H8O2),CHCl3
Crystal Growth & Design (2011) 11, 6 2637
a=17.213(3)Å b=8.4780(17)Å c=21.650(4)Å
α=90° β=91.04(3)° γ=90°
Orcinol: N,N-dimethyl,4-aminopyridine
2(C7H10N2),C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=7.8586(19)Å b=8.1455(19)Å c=16.239(4)Å
α=83.929(6)° β=81.521(6)° γ=86.524(6)°
Orcinol:Pyrazine
C7H8O2,0.5(C4H4N2)
Crystal Growth & Design (2011) 11, 6 2637
a=6.9967(14)Å b=8.5801(17)Å c=13.531(3)Å
α=90° β=95.16(3)° γ=90°
Orcinol:Piperazine
C7H8O2,C4H10N2
Crystal Growth & Design (2011) 11, 6 2637
a=7.2456(12)Å b=12.316(2)Å c=12.590(2)Å
α=90° β=96.268(7)° γ=90°
Orcinol:Acridine
2(C13H9N),C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=7.837(2)Å b=9.702(3)Å c=17.830(5)Å
α=98.229(7)° β=100.908(7)° γ=103.819(7)°
Orcinol:Pyrimidine
C7H8O2,C4H5N3
Crystal Growth & Design (2011) 11, 6 2637
a=8.7636(7)Å b=10.9081(9)Å c=13.3171(11)Å
α=112.508(8)° β=104.169(7)° γ=92.570(7)°
Orcinol:Phenazine
2(C12H8N2),C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=8.1760(16)Å b=9.2940(19)Å c=16.888(3)Å
α=102.32(3)° β=102.03(3)° γ=93.53(3)°
Orcinol:aminodimethylpyrimidine
2(C6H9N3),C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=8.4494(9)Å b=12.3620(13)Å c=19.748(2)Å
α=83.323(7)° β=77.689(7)° γ=89.497(6)°
Orcinol:Phenantrholine
2(C12H8N2),C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=13.783(7)Å b=13.520(7)Å c=15.981(6)Å
α=90° β=124.11(3)° γ=90°
Orcinol:Acridine Hydrate
2(C13H9N),2(C7H8O2),H2O
Crystal Growth & Design (2011) 11, 6 2637
a=9.3390(7)Å b=25.441(2)Å c=13.7503(11)Å
α=90° β=90° γ=90°
Orcinol:1245Tetracyanobenzene
C7H8O2,1.5(C10H2N4)
Crystal Growth & Design (2011) 11, 6 2637
a=7.2000(14)Å b=7.5989(15)Å c=35.894(7)Å
α=90° β=91.01(3)° γ=90°
Orcinol:4(N,N-dimethylaminopyridine
C7H10N2,C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=10.498(8)Å b=8.887(7)Å c=15.557(9)Å
α=90° β=113.80(4)° γ=90°
OrcinolHexamine
C6H12N4,C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=17.572(3)Å b=21.702(4)Å c=7.0650(14)Å
α=90° β=90° γ=90°
Orcinol:Nicotinamide
C7H8O2,4(C6H6N2O),H2O
Crystal Growth & Design (2011) 11, 6 2637
a=7.9260(16)Å b=12.560(3)Å c=16.750(3)Å
α=96.16(3)° β=99.97(3)° γ=98.56(3)°
Orcinol:Isonicotinamide
C7H8O2,2(C6H6N2O)
Crystal Growth & Design (2011) 11, 6 2637
a=33.630(7)Å b=7.2600(15)Å c=15.358(3)Å
α=90° β=95.65(3)° γ=90°
(Orcinol:Nicotinamide)
C7H8O2,4(C6H6N2O)
Crystal Growth & Design (2011) 11, 6 2637
a=8.2817(12)Å b=10.9094(12)Å c=16.600(2)Å
α=99.961(9)° β=96.163(7)° γ=93.253(5)°
Orcinol form II
C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=13.784(14)Å b=16.174(17)Å c=24.55(2)Å
α=90° β=90° γ=90°
Orcinol:Quinoxaline
C7H8O2,2(C8H6N2)
Crystal Growth & Design (2011) 11, 6 2637
a=7.0702(14)Å b=14.274(3)Å c=19.730(4)Å
α=90° β=99.05(3)° γ=90°
Orcinol:Quinoxaline2:1
2(C7H8O2),C8H6N2
Crystal Growth & Design (2011) 11, 6 2637
a=8.2900(17)Å b=9.990(2)Å c=12.690(3)Å
α=104.66(3)° β=103.82(3)° γ=96.33(3)°
Orcinol:N,NdimethylaminoPyridne
C7H8O2,2(C7H10N2)
Crystal Growth & Design (2011) 11, 6 2637
a=13.845(3)Å b=9.6116(17)Å c=15.059(3)Å
α=90° β=97.096(7)° γ=90°
Orcinol:H2O
C7H8O2,H2O
Crystal Growth & Design (2011) 11, 6 2637
a=9.899(2)Å b=7.9510(16)Å c=9.1707(18)Å
α=90° β=96.88(3)° γ=90°
C13H8N2O5
C13H8N2O5
Crystal Growth & Design (2015) 15, 7 3280
a=7.509(4)Å b=7.967(5)Å c=10.623(8)Å
α=75.53(3)° β=83.95(5)° γ=69.20(3)°
C13H8N2O5
C13H8N2O5
Crystal Growth & Design (2015) 15, 7 3280
a=18.94(2)Å b=5.029(6)Å c=6.071(8)Å
α=90° β=90° γ=90°
C7H5NO4
C7H5NO4
Crystal Growth & Design (2015) 15, 7 3280
a=20.98(13)Å b=5.03(3)Å c=12.85(7)Å
α=90° β=97.20(8)° γ=90°
4-(acetylamino)-benzoic acid
C9H9NO3
Crystal Growth & Design (2011) 11, 2 616
a=5.0255(13)Å b=6.8219(13)Å c=12.196(3)Å
α=89.254(7)° β=80.804(7)° γ=79.282(5)°
1-Acetamido-4-methylbenzene
C9H11NO
Crystal Growth & Design (2011) 11, 2 616
a=11.662(1)Å b=9.4694(8)Å c=7.3997(6)Å
α=90° β=106.559(7)° γ=90°
P-acetamidobenzoic acid
C9H9NO3
Crystal Growth & Design (2011) 11, 2 616
a=5.0299(2)Å b=6.8310(3)Å c=12.1945(5)Å
α=89.227(2)° β=80.846(2)° γ=79.318(2)°
P-methoxy benzoic acid
C8H8O3
Crystal Growth & Design (2011) 11, 2 616
a=3.8760(3)Å b=10.9298(9)Å c=16.620(1)Å
α=90° β=93.383(4)° γ=90°
P-methyl benzoic acid
C8H8O2
Crystal Growth & Design (2011) 11, 2 616
a=7.2832(3)Å b=7.4255(3)Å c=7.8100(3)Å
α=96.067(2)° β=108.353(2)° γ=117.701(2)°
Acetanilide
C8H9NO
Crystal Growth & Design (2011) 11, 2 616
a=9.3710(9)Å b=7.7868(8)Å c=19.530(2)Å
α=90° β=90° γ=90°
C10H10N2S3
C10H10N2S3
Acta Crystallographica Section B Structural Science (2009) 65, 2 107-125
a=13.060(3)Å b=9.738(2)Å c=9.335(2)Å
α=90.00° β=105.800(3)° γ=90.00°
Orcinol:4-CyanoPyridine
2(C7H8O2),C6H4N2
Crystal Growth & Design (2011) 11, 6 2637
a=7.495(2)Å b=17.596(5)Å c=14.389(4)Å
α=90° β=97.656(7)° γ=90°
Orcinol
C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=20.060(3)Å b=20.060(3)Å c=6.4230(13)Å
α=90° β=90° γ=90°